0
Article |

The Treatment of Tinea Capitis with Orally Administered Griseofulvin

VICTOR D. NEWCOMER, M.D.; RICHARD S. HOMER, M.D.; RONALD M. REISNER, M.D.; LLOYD J. SORENSEN, Ph.D.; EARL G. McNALL, Ph.D.; THOMAS H. STERNBERG, M.D.
AMA Am J Dis Child. 1960;99(5):585-596. doi:10.1001/archpedi.1960.02070030587004.
Text Size: A A A
Published online

The changing epidemiological pattern of tinea capitis during the past two decades has emphasized the urgent need for an effective, simple, and relatively safe fungicidal agent. In this country, prior to 1940, approximately 80% of cases of tinea capitis were due to either Microsporum canis or Microsporum audouini. The number of cases of tinea capitis were comparatively small, and the incidence of disease due to these two organisms was approximately equal with local variations.1-4

During 1941 and 1942, in New York, there was observed a gradual increase in the number of cases of tinea capitis due to M. audouini. This gradual increase was followed, in 1943, by a sharp rise in the incidence of tinea capitis produced predominantly by this organism.1,4-6 In the ensuing five or six years the incidence of the disease produced by M. audouini increased to epidemic proportions and spread from New York to Albany,

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs